malaria

Documents about malaria

• 22 U.S.C. § 7633 — Assistance to combat malaria#578023US Code (LII)
• 22 U.S.C. § 7634 — Malaria response Coordinator#578024US Code (LII)
• 22 U.S.C. § 7622 — Participation in the Global Fund to Fight AIDS, Tuberculosis and Malaria#578028US Code (LII)
• 22 U.S.C. § 7623 — Combating HIV/AIDS, tuberculosis, and malaria by strengthening health policies and health systems of partner countries#578029US Code (LII)
• 22 U.S.C. § 2151b-1 — Assistance for malaria prevention, treatment, control, and elimination#579580US Code (LII)
• 22 U.S.C. § 2151b-4 — Assistance to combat malaria#579583US Code (LII)
• Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth#18675ClinicalTrials.gov
• A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months#18699ClinicalTrials.gov
• A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M#67690ClinicalTrials.gov
• Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines#121465ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria#343684ClinicalTrials.gov
• AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area#343707ClinicalTrials.gov
• Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults#346993ClinicalTrials.gov
• Seasonal R21 Mass Vaccination for Malaria Elimination#350011ClinicalTrials.gov
• Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)#363631ClinicalTrials.gov
• Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men#363664ClinicalTrials.gov
• <b>HOUSEHOLD KNOWLEDGE, ATTITUDES, AND PRACTICES (KAP) TOWARD MALARIA PREVENTION</b><b> IN CAMEROON</b>#191667Figshare
• Variable effects of non-falciparum species infections on malaria disease severity in high transmission regions in Senegal#300941HAL (France)
• Persistent carriage of subpatent Plasmodium falciparum parasites associated with clinical malaria in a low transmission area in Senegal#300943HAL (France)
• Common Molecular Detection of the Neglected Human Malaria Parasite Among Febrile Patients in Southern Regions in Senegal#300947HAL (France)
• Performance and usability evaluation of three LDH-based malaria rapid diagnostic tests in Kédougou, Senegal#300948HAL (France)
• Malaria misdiagnosis among febrile patients in Senegal: implications for the underestimation of Plasmodium species diversity and malaria burden#300954HAL (France)

Related topics